MA

Muslim Abbas

Active Director Director DIN 05134895
DIN 05134895 First appointment Dec 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2011
Shareholding value •••• Premium profile

About Muslim Abbas

Data last updated:

Muslim Abbas is a Director at Winmark Pharmaceuticals Private Limited (since 2011). The company operates in Pharma. Winmark Pharmaceuticals Private Limited reported revenue of ₹5.64 Cr (FY 2019).

DIN 05134895
Primary Designation Director
Industry Pharma
First Appointment 30 Dec 2011
Oldest Company Age 14 yrs
Largest company Winmark Pharmaceuticals Private Limited · ₹5.64 Cr (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Dec 20112011₹5.64 Cr (FY 2019)Active

Board colleagues of Muslim Abbas

NameDINCompanyDesignation
Mohammed Hasan05134992Winmark Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Winmark Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Muslim Abbas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muslim Abbas

Muslim Abbas currently holds 1 directorship: Winmark Pharmaceuticals Private Limited (Director, since 30 Dec 2011, revenue ₹5.64 Cr (FY 2019)).

Muslim Abbas was first appointed on 30 Dec 2011 as Director at Winmark Pharmaceuticals Private Limited.

The current boards of Muslim Abbas's companies include Mohammed Hasan (Winmark Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available